In total, 7 of 18 (39%) patients with neuropathic pain also met our criteria for SFI.5 Distribution among the patient groups was 4 NF1, 1 SWN-NF2, and 2 SWN-NOS. The gene discussed is NF2; the disease is neurofibromatosis type 1.